drugset / Trial / NCT04384445
Zofin (Organicell Flow) for Patients With COVID-19
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this research study is to evaluate the safety and potential efficacy of Intravenous Infusion of Zofin for treatment of moderate to severe Acute Respiratory Syndrome (SARS) related to COVID-19 infection vs Placebo.
Timeline
- Start
- 2020-09-08
- Primary completion
- 2023-07-01
- Completion
- 2023-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zofin | Other / unclassified | 1 ml | Intravenous |